EMC7
gene geneOn this page
Also known as C11orf3
Summary
EMC7 (ER membrane protein complex subunit 7, HGNC:24301) is a protein-coding gene on chromosome 15q14, encoding Endoplasmic reticulum membrane protein complex subunit 7 (Q9NPA0). Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. It is a selective cancer dependency (DepMap: 71.5% of cell lines).
Contributes to membrane insertase activity. Involved in protein insertion into ER membrane by stop-transfer membrane-anchor sequence and tail-anchored membrane protein insertion into ER membrane. Located in endoplasmic reticulum membrane. Part of EMC complex.
Source: NCBI Gene 56851 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 35 total
- Cancer dependency (DepMap): dependent in 71.5% of screened cell lines
- MANE Select transcript:
NM_020154
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24301 |
| Approved symbol | EMC7 |
| Name | ER membrane protein complex subunit 7 |
| Location | 15q14 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | C11orf3 |
| Ensembl gene | ENSG00000134153 |
| Ensembl biotype | protein_coding |
| OMIM | 620631 |
| Entrez | 56851 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000256545, ENST00000527822, ENST00000528949, ENST00000532113, ENST00000880067, ENST00000917774, ENST00000917775, ENST00000961768
RefSeq mRNA: 1 — MANE Select: NM_020154
NM_020154
CCDS: CCDS10032
Canonical transcript exons
ENST00000256545 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000912984 | 34095895 | 34096014 |
| ENSE00001043239 | 34090317 | 34090455 |
| ENSE00001043245 | 34088053 | 34088133 |
| ENSE00001232334 | 34084017 | 34084486 |
| ENSE00001232339 | 34101604 | 34101862 |
Expression profiles
Bgee: expression breadth ubiquitous, 293 present calls, max score 98.03.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 60.5240 / max 301.7031, expressed in 1827 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 149222 | 59.4158 | 1827 |
| 149223 | 1.1082 | 739 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| decidua | UBERON:0002450 | 98.03 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 97.88 | gold quality |
| type B pancreatic cell | CL:0000169 | 97.84 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.12 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.05 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 97.03 | gold quality |
| male germ cell | CL:0000015 | 97.01 | gold quality |
| sperm | CL:0000019 | 96.96 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.95 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.92 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.89 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.72 | gold quality |
| spinal cord | UBERON:0002240 | 96.70 | gold quality |
| hypothalamus | UBERON:0001898 | 96.65 | gold quality |
| rectum | UBERON:0001052 | 96.59 | gold quality |
| adrenal gland | UBERON:0002369 | 96.59 | gold quality |
| thoracic aorta | UBERON:0001515 | 96.58 | gold quality |
| ascending aorta | UBERON:0001496 | 96.56 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 96.54 | gold quality |
| caudate nucleus | UBERON:0001873 | 96.51 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 96.50 | gold quality |
| substantia nigra | UBERON:0002038 | 96.43 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.37 | gold quality |
| nucleus accumbens | UBERON:0001882 | 96.36 | gold quality |
| putamen | UBERON:0001874 | 96.28 | gold quality |
| left coronary artery | UBERON:0001626 | 96.27 | gold quality |
| placenta | UBERON:0001987 | 96.25 | gold quality |
| adult organism | UBERON:0007023 | 96.24 | gold quality |
| right testis | UBERON:0004534 | 96.19 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-93593 | no | 7.55 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): SP1, SP3, TCF3
miRNA regulators (miRDB)
41 targeting EMC7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-1197 | 99.70 | 67.75 | 1027 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-2113 | 99.58 | 71.22 | 1521 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-199A-5P | 99.51 | 69.71 | 1107 |
| HSA-MIR-199B-5P | 99.51 | 69.74 | 1098 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-32-3P | 99.36 | 68.20 | 2517 |
| HSA-MIR-1244 | 99.33 | 68.38 | 832 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
| HSA-MIR-5190 | 99.15 | 67.76 | 1234 |
| HSA-MIR-629-5P | 98.78 | 68.72 | 1032 |
| HSA-MIR-4782-5P | 98.35 | 69.33 | 1474 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 71.5% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- Candidate modifier gene on the phenotypic expression of hypertrophy in patients with hyperthophic cardiomyopathy. (PMID:17165166)
- ER membrane protein complex subunit 4 (EMC4) and EMC7 support SV40 infection by promoting from the late endosome (LE) to the endoplasmic reticulum (ER) targeting of the virus. They do this by engaging LE-associated Rab7, to stabilize contact between the LE and ER. These EMC subunits also bind to the ER-resident fusion machinery component syntaxin18, which is required for SV40-arrival to the ER. (PMID:32111841)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | emc7b | ENSDARG00000012144 |
| danio_rerio | emc7a | ENSDARG00000102983 |
| mus_musculus | Emc7 | ENSMUSG00000055943 |
| rattus_norvegicus | Emc7 | ENSRNOG00000005884 |
| drosophila_melanogaster | EMC7 | FBGN0034066 |
| caenorhabditis_elegans | WBGENE00016439 |
Protein
Protein identifiers
Endoplasmic reticulum membrane protein complex subunit 7 — Q9NPA0 (reviewed: Q9NPA0)
Alternative names: ER membrane protein complex subunit 7
All UniProt accessions (3): Q9NPA0, H0YDT8, H0YDX2
UniProt curated annotations — full annotation on UniProt →
Function. Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes.
Subunit / interactions. Component of the ER membrane protein complex (EMC).
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the EMC7 family.
RefSeq proteins (1): NP_064539* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013784 | Carb-bd-like_fold | Homologous_superfamily |
| IPR019008 | Beta_sandwich_EMC7 | Domain |
| IPR039163 | EMC7 | Family |
Pfam: PF09430
UniProt features (24 total): strand 12, helix 3, topological domain 2, turn 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
14 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 1LP9 | X-RAY DIFFRACTION | 2 |
| 2UWE | X-RAY DIFFRACTION | 2.4 |
| 1B0G | X-RAY DIFFRACTION | 2.5 |
| 2JCC | X-RAY DIFFRACTION | 2.5 |
| 2J8U | X-RAY DIFFRACTION | 2.88 |
| 8J0O | ELECTRON MICROSCOPY | 3.32 |
| 7ADO | ELECTRON MICROSCOPY | 3.39 |
| 6WW7 | ELECTRON MICROSCOPY | 3.4 |
| 8EOI | ELECTRON MICROSCOPY | 3.4 |
| 8J0N | ELECTRON MICROSCOPY | 3.47 |
| 8S9S | ELECTRON MICROSCOPY | 3.6 |
| 9ZZ6 | ELECTRON MICROSCOPY | 4.16 |
| 6Z3W | ELECTRON MICROSCOPY | 6.4 |
| 9C7V | ELECTRON MICROSCOPY | 6.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NPA0-F1 | 74.54 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 135 (showing top):
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, chr15q14, ONKEN_UVEAL_MELANOMA_UP, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_MEMBRANE_ORGANIZATION, GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION, CUI_TCF21_TARGETS_2_DN, ATGTCAC_MIR489, GOBP_LOCALIZATION_WITHIN_MEMBRANE, GOBP_PROTEIN_INSERTION_INTO_MEMBRANE, LAIHO_COLORECTAL_CANCER_SERRATED_UP, PAX6_01, GOCC_MEMBRANE_PROTEIN_COMPLEX
GO Biological Process (2): protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050), tail-anchored membrane protein insertion into ER membrane (GO:0071816)
GO Molecular Function (3): carbohydrate binding (GO:0030246), protein binding (GO:0005515), membrane insertase activity (GO:0032977)
GO Cellular Component (4): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), EMC complex (GO:0072546), endoplasmic reticulum (GO:0005783)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein insertion into ER membrane | 2 |
| binding | 2 |
| establishment of protein localization to membrane | 1 |
| protein carrier activity | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| endoplasmic reticulum membrane | 1 |
| membrane protein complex | 1 |
| endoplasmic reticulum protein-containing complex | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1022 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EMC7 | EMC4 | Q5J8M3 | 869 |
| EMC7 | EMC1 | Q8N766 | 864 |
| EMC7 | MMGT1 | Q8N4V1 | 852 |
| EMC7 | EMC3 | Q9P0I2 | 827 |
| EMC7 | LTAP1 | Q9BWL3 | 818 |
| EMC7 | EMC6 | Q9BV81 | 806 |
| EMC7 | EMC10 | Q5UCC4 | 786 |
| EMC7 | EMC8 | O43402 | 748 |
| EMC7 | EMC9 | Q9Y3B6 | 747 |
| EMC7 | EMC2 | Q15006 | 710 |
| EMC7 | CHMP2A | O43633 | 707 |
| EMC7 | PSMB4 | P28070 | 640 |
| EMC7 | PSMB2 | P31145 | 634 |
| EMC7 | TMEM147 | Q9BVK8 | 587 |
| EMC7 | VPS29 | Q9UBQ0 | 540 |
IntAct
174 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EMC2 | EMC8 | psi-mi:“MI:0914”(association) | 0.940 |
| EMC8 | EMC2 | psi-mi:“MI:0914”(association) | 0.940 |
| EMC2 | EMC10 | psi-mi:“MI:0914”(association) | 0.800 |
| EMC7 | EMC8 | psi-mi:“MI:0914”(association) | 0.790 |
| EMC3 | EMC8 | psi-mi:“MI:0914”(association) | 0.730 |
| MMGT1 | EMC8 | psi-mi:“MI:0914”(association) | 0.730 |
| TMED9 | TMED10 | psi-mi:“MI:0914”(association) | 0.730 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| KLHL22 | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| EMC1 | EMC8 | psi-mi:“MI:0914”(association) | 0.640 |
BioGRID (276): EMC9 (Affinity Capture-MS), UBQLN2 (Affinity Capture-MS), EMC8 (Affinity Capture-MS), EMC2 (Affinity Capture-MS), EMC3 (Affinity Capture-MS), EMC10 (Affinity Capture-MS), CLPTM1L (Affinity Capture-MS), EMC6 (Affinity Capture-MS), MMGT1 (Affinity Capture-MS), EMC1 (Affinity Capture-MS), EMC7 (Affinity Capture-MS), EMC7 (Affinity Capture-MS), EMC7 (Affinity Capture-MS), EMC7 (Affinity Capture-MS), EMC7 (Affinity Capture-MS)
ESM2 similar proteins: A5D8P8, A5PJA8, A6QLP7, A7E2Z9, A9SV59, B5DDX6, E2RQ08, F1QR43, F1R777, F4JVN6, O12940, O18756, O64614, O94923, P04843, P07153, P16967, P43307, P45433, P51571, P53815, Q04499, Q05AW9, Q07984, Q0IHY5, Q0J6P7, Q2M146, Q2TBX5, Q3UFM5, Q4R4T0, Q4R5V2, Q5R4X4, Q5REH6, Q5RFB6, Q5TYV0, Q5ZJT0, Q62186, Q6P7K5, Q7ZV50, Q8BXQ2
Diamond homologs: A5PJA8, Q0IHY5, Q4R5V2, Q5TYV0, Q8WQG1, Q9EP72, Q9NPA0
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| EMC7 | “form complex” | “Endoplasmic reticulum membrane complex- EMC9 variant” | binding |
| EMC7 | “form complex” | “Endoplasmic reticulum membrane complex, EMC8 variant” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 159 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| COPI-dependent Golgi-to-ER retrograde traffic | 6 | 6.6× | 7e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| tail-anchored membrane protein insertion into ER membrane | 9 | 62.4× | 2e-12 |
| ERAD pathway | 8 | 10.7× | 2e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
757 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:34085533:T:TA | donor_gain | 1.0000 |
| 15:34088052:CCCGT:C | donor_gain | 1.0000 |
| 15:34088130:TAAC:T | acceptor_gain | 1.0000 |
| 15:34088130:TAACC:T | acceptor_loss | 1.0000 |
| 15:34088131:AACC:A | acceptor_loss | 1.0000 |
| 15:34088132:ACCT:A | acceptor_loss | 1.0000 |
| 15:34088134:C:CA | acceptor_loss | 1.0000 |
| 15:34088135:T:C | acceptor_loss | 1.0000 |
| 15:34090469:A:C | acceptor_gain | 1.0000 |
| 15:34095889:CCTCA:C | donor_loss | 1.0000 |
| 15:34095890:CTCA:C | donor_loss | 1.0000 |
| 15:34095891:TCAC:T | donor_loss | 1.0000 |
| 15:34095892:CA:C | donor_loss | 1.0000 |
| 15:34095894:C:CG | donor_loss | 1.0000 |
| 15:34095894:CCT:C | donor_gain | 1.0000 |
| 15:34096010:CTGTC:C | acceptor_gain | 1.0000 |
| 15:34096014:CCT:C | acceptor_loss | 1.0000 |
| 15:34096015:C:CC | acceptor_gain | 1.0000 |
| 15:34096015:CTG:C | acceptor_loss | 1.0000 |
| 15:34096016:T:C | acceptor_loss | 1.0000 |
| 15:34101602:A:AC | donor_gain | 1.0000 |
| 15:34101603:C:CC | donor_gain | 1.0000 |
| 15:34101606:A:AC | donor_gain | 1.0000 |
| 15:34101766:T:TA | donor_gain | 1.0000 |
| 15:34084483:TTTC:T | acceptor_gain | 0.9900 |
| 15:34084484:TTCC:T | acceptor_loss | 0.9900 |
| 15:34084485:TCCT:T | acceptor_loss | 0.9900 |
| 15:34084486:CCTG:C | acceptor_loss | 0.9900 |
| 15:34084487:C:CC | acceptor_gain | 0.9900 |
| 15:34084487:CTG:C | acceptor_loss | 0.9900 |
AlphaMissense
1569 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:34088105:A:T | I175K | 1.000 |
| 15:34088114:G:C | P172R | 1.000 |
| 15:34088117:A:T | L171H | 1.000 |
| 15:34088123:A:C | M169R | 1.000 |
| 15:34088123:A:T | M169K | 1.000 |
| 15:34095994:A:T | V86D | 1.000 |
| 15:34096000:A:G | F84S | 1.000 |
| 15:34084431:G:A | S211F | 0.999 |
| 15:34084434:A:T | V210D | 0.999 |
| 15:34084474:A:G | S197P | 0.999 |
| 15:34088096:A:T | L178H | 0.999 |
| 15:34088105:A:C | I175R | 0.999 |
| 15:34088114:G:T | P172H | 0.999 |
| 15:34088117:A:C | L171R | 0.999 |
| 15:34088120:A:T | V170D | 0.999 |
| 15:34088126:A:C | M168R | 0.999 |
| 15:34088126:A:T | M168K | 0.999 |
| 15:34090347:C:A | W155C | 0.999 |
| 15:34090347:C:G | W155C | 0.999 |
| 15:34090399:A:T | L138H | 0.999 |
| 15:34090453:G:T | A120E | 0.999 |
| 15:34095922:A:T | V110E | 0.999 |
| 15:34095925:C:G | R109P | 0.999 |
| 15:34095999:A:C | F84L | 0.999 |
| 15:34095999:A:T | F84L | 0.999 |
| 15:34096001:A:G | F84L | 0.999 |
| 15:34101614:C:G | G76R | 0.999 |
| 15:34101657:C:A | W61C | 0.999 |
| 15:34101657:C:G | W61C | 0.999 |
| 15:34101659:A:G | W61R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000229375 (15:34093603 G>A), RS1000644837 (15:34087234 C>T), RS1000861747 (15:34093361 C>A,G,T), RS1001014061 (15:34099153 T>A,C), RS1001105038 (15:34093532 A>G), RS1001325299 (15:34100517 C>T), RS1001545947 (15:34099835 G>A,C), RS1001561993 (15:34097565 G>A), RS1001724441 (15:34092997 T>A,C), RS1001988441 (15:34097275 C>T), RS1002515518 (15:34098779 C>A,G,T), RS1002726343 (15:34101414 C>T), RS1002751173 (15:34101103 T>G), RS1002960335 (15:34098430 A>G), RS1003330136 (15:34095757 G>A)
Disease associations
OMIM: gene MIM:620631 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_22 | Malaria | 3.000000e-06 |
| GCST010725_37 | Malaria | 3.000000e-06 |
| GCST010725_54 | Malaria | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 4 |
| bisphenol A | decreases expression, affects expression | 2 |
| Arsenic | increases expression, affects cotreatment, increases abundance | 2 |
| Valproic Acid | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| bleomycetin | decreases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| chloropicrin | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.